Skip to content
AtheroMed logo — Innovative solutions for peripheral arterial disease since 2...

AtheroMed

Innovative solutions for peripheral arterial disease since 2006, based in Menlo Park, California.

Founded 2006 Debt Financing Total: $43.71M Biotechnology, Health Care +1

General Information

Company Name AtheroMed
Founded Year 2006
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with AtheroMed. To contact AtheroMed, visit atheromedinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AtheroMed compare?

A PDF of AtheroMed and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AtheroMed soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AtheroMed

AtheroMed is a biotechnology startup based in Menlo Park, California, specializing in innovative solutions for peripheral arterial disease. Founded in 2006, the company has been dedicated to developing treatments for this critical health issue. AtheroMed's commitment to addressing peripheral arterial disease has attracted attention and investment, with their last round of Debt Financing amounting to $4.35M on 10 December 2013. While the details of their investors for this round are not publicly available, this investment signifies a recognition of the potential and value of AtheroMed's work in the biotechnology and healthcare industries. With a focus on innovation and a solid foundation, AtheroMed continues to drive progress in the field of peripheral arterial disease treatment.

Business keywords: Peripheral Arterial Disease, Innovative Solutions, Vascular Health, Menlo Park, California, Treatment Development, Medical Technology, Biomedical Innovation

Funding Rounds & Investors (7)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $4.35M -
10 Dec 2013
Private Equity Round $5.96M 4
Canaan Partners, Kaiser Permanente Ventures +2
03 Apr 2013
Private Equity Round $13.00M 1
The Vertical Group
01 Apr 2012
Series D $4.48M 3
Canaan Partners, Kaiser Permanente Ventures +1
07 Mar 2012
Venture Round $7.53M -
09 May 2011
Venture Round $2.36M -
11 Dec 2009
Series A $6.04M 1
US Venture Partners
23 Jan 2008

AtheroMed Alternatives & Competitors

View All Alternatives
AtheroMed vs

Innovative solutions for coronary and peripheral vascular treatments with cutting-edge bioabsorbable...

Debt Financing
Biotechnology, Health Care
AtheroMed vs

Pioneering targeted drug delivery for innovative peripheral artery disease therapy.

Series A
Biotechnology, Health Care
AtheroMed vs

Innovative solutions for advanced cardiovascular specialty catheters in Interventional Cardiology, E...

Venture round
Health Care, Medical Devices

FAQ About AtheroMed

Innovative solutions for peripheral arterial disease since 2006, based in Menlo Park, California.
AtheroMed was founded in 2006.
AtheroMed operates in Biotechnology, Health Care and Medical Devices. Its work centres on Peripheral Arterial Disease, Innovative Solutions, Vascular Health and Menlo Park.
AtheroMed has completed 7 funding rounds, raising a total of $43.71M. The latest funding stage is Debt Financing.
Top alternatives and competitors to AtheroMed include Bioabsorbable Therapeutics, Vascular Magnetics, Roxwood Medical, Pathway Medical Technologies, Cagent Vascular. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AtheroMed and Bioabsorbable Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AtheroMed, https://bouncewatch.com/company/atheromed, updated 27 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout